| CTGF expression |  | |
---|---|---|---|
 | Negative | Positive | P value |
Gender | Â | Â | Â |
Male | 33 | 34 | 0.779 |
Female | 20 | 23 | Â |
Age (years) | Â | Â | Â |
≤ 65 | 35 | 40 | 0.642 |
> 65 | 18 | 17 | Â |
Tumor size (cm) | Â | Â | Â |
< 5 | 26 | 25 | 0.585 |
≥ 5 | 27 | 32 |  |
Tumor location | Â | Â | Â |
Lower | 42 | 37 | 0.413 |
Middle | 5 | 8 | Â |
Upper | 3 | 6 | Â |
Entire | 3 | 6 | Â |
Histologic grade | Â | Â | Â |
Differentiated | 26 | 17 | 0.039* |
Undifferentiated | 27 | 40 | Â |
Lauren grade | Â | Â | Â |
Intestinal | 28 | 21 | 0.108 |
Diffuse | 25 | 36 | Â |
Lymph node metastasis | Â | Â | Â |
Negative | 23 | 12 | 0.012* |
Positive | 30 | 45 | Â |
TNM stage | Â | Â | Â |
I | 11 | 8 | 0.080 |
II | 15 | 9 | Â |
III | 20 | 22 | Â |
IV | 7 | 18 | Â |
Hepatic metastasis | Â | Â | Â |
Negative | 50 | 55 | 0.588 |
Positive | 3 | 2 | Â |
Peritoneal dissemination | Â | Â | Â |
Negative | 50 | 44 | 0.011* |
Positive | 3 | 13 | Â |